About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when
May 27, 2022 |
Jessica Bassett
ViiV ‘actively negotiating’ voluntary licence for HIV prevention drug
Maryland-based Novavax has sent millions of COVID vaccine doses to wealthy nations and none to the initiative that supplies poorer countries
Related Posts
Access to Medicines
Pharma’s alleged “brea...
PEPFAR Watch
PEPFAR is Rolling the Cloc...
Access to Medicines
Pharma Pricing Secrecy Run...